August 15, 2024911±¬ÁÏ’s popular FOCUS outreach program marks its 10th anniversary this summer and continues to expand its science and tech immersion programs.
August 9, 2024As 911±¬ÁÏ doctoral student Jericho McLeod reviewed literature on disease transmission as part of his PhD work, he and 911±¬ÁÏ professor Eduardo López noticed a gap in the models and now seek to correct it.
July 25, 2024Researchers in 911±¬ÁÏ’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study, published in Nature’s Gene Therapy, that found a human immunodeficiency virus (HIV)-like virus particle that could cease the need for lifelong medications.
July 14, 2024The Virginia Board of Education approved funding for 911±¬ÁÏ to launch the Shenandoah Valley Rural Regional College Partnership Laboratory School for Data Science, Computing, and Applications (DSCA).
July 11, 2024Their study, published in the Journal of Proteome Research, involved extracting wheat proteins from three small leather cover samples obtained from the National Library of Medicine.
June 25, 2024Emily Poindexter received funding from the Virginia Native Plant Society to support her study of Ozark Milkvetch, a small, perennial plant native to south-central United States
November 7, 2023A Mason research team is developing a CropSmart Digital Twin to support farmers with increasing crop production and decreasing environmental footprint.
October 25, 2023Mason researcher Fereshte Ghahari Kermani recently received the highly competitive U.S. Department of Energy (DOE) Early Career Award. She is the first Mason faculty member to receive this honor, one that highlights the significance of her contributions to the field of condensed matter physics.
April 28, 2023Chemistry in the Kitchen is a new course offered at 911±¬ÁÏ that uses everyday recipes to demonstrate chemical concepts taught in the classroom.
March 14, 2022A $1.57 million grant from the Department of Army, U.S. Army Medical Research Acquisition Activity, will help support a transformative approach for breast cancer treatment developed by scientists in Mason’s Center for Drug Discovery for Rare Diseases.
